ORTEXORTEX News
Tracking CACI? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CA
Earnings PreviewCACI

CACI Q1 Preview: Analyst Upgrades Meet a Cautious Short Book

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 22 Oct 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

CACI International arrives at its fiscal first-quarter print on October 22 with the stock up 3.2% over the past week to $623.38, trailing a peer median of roughly 5.3%, while short sellers have added positions at the margin even as the broader lending market stays wide open.

Short interest edged up nearly 2% on October 20 to 1.06 million shares, or 4.8% of the free float. That is down 8% from the intra-month peak of around 1.19 million shares hit in mid-October, and up about 15% from where it stood a month ago. The borrow market offers no amplification: availability is exceptionally loose at 1,522% of shares short, and the cost to borrow is 0.42%. Neither figure suggests any squeeze pressure on the short side. Options positioning remains call-skewed, with the put/call ratio at 0.26, slightly above the 52-week low of 0.24 reached earlier this week but still below its 20-day average of 0.26. The lean is bullish, but only mildly so compared to the more extreme call skew seen a few sessions ago.

The analyst community sharpened its view in the days before the print. Cantor Fitzgerald raised its price target to $785 from $675 yesterday, maintaining Overweight. Macquarie initiated coverage at Outperform with an $780 target last week. Those moves sit against Citigroup's Neutral and BNP Paribas's Underperform, the latter with a $540 target that remains well below the current price. The mean target across the analyst group is $740, roughly 19% above where the stock trades. The core disagreement is about contract momentum. The bull case rests on a focused bidding strategy, raised full-year revenue guidance of $9.3 billion to $9.5 billion, and free cash flow that reached $281 million year-to-date. The bear case centers on the FQ2 revenue miss, a book-to-bill ratio of just 0.6x, and a funded backlog that has been shrinking, raising questions about whether mid-single-digit growth is achievable if the federal contracting environment stays difficult.

The institutional register shows limited change. BlackRock holds about 9.9% and added shares through September. Barrow Hanley made a more notable move, building its position by over 690,000 shares as of the July reporting date. Insider activity in the past week was confined to option exercises and tax-withholding transactions by the corporate controller, all compensation mechanics rather than open-market conviction trades. The 90-day net insider position nets to zero.

The print will test whether CACI's backlog and bookings trajectory is recovering from the weak FQ2 reading, and whether management's revenue guidance range still holds after a quarter marked by federal budget uncertainty.

Stocks in this article

See the live data behind this article on ORTEX.

Open CACI on ORTEX →

How this article was generated

Generated
22 Oct 2026, 04:05
Data as of
22 Oct 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.